The concept of a "cancer stem cell system" that continues to supply cancer component cells has been proposed. It is time to apply stem cell studies, which is a field of expertise in regenerative medicine, to cancer treatment. Cancer treatments that effectively attack cancer stem cells acting as a manufacturing plant for producing differentiated cancer progenies will be designed by revealing the cancer stem cell system. Therefore, in the near future we hope that revolution will occur in cancer therapy to eradicate cancer and prevent the recurrence thereof. In this review we discuss the current situation and problems of cancer stem cell research.
INTRODUCTION
if a single cancer stem cell remains. Therefore, if cancer stem cells can be effectively removed, then cancer can also be effectively eradicated. It has been suggested that Stem cells are undifferentiated cells that combine self-renewal capability with differentiation capability. normal and cancer stem cells have potentially many common mechanisms for governing their populations. The cells are destined to develop into various cell lineages and mature to eventually become functioning tis-Controlling the number of stem cells and clarifying the mechanism for determining cell fate can greatly contrib-sue-differentiating cells. Cells with short life spans, such as blood cells, cutaneous cells, and gastrointestinal ute not only to the development of regenerative medicine but also to cancer therapy. Therefore, this review mucosal epithelial cells, can avoid becoming depleted because the stem cells of such regions are constantly describes the current situation and future prospects of cancer stem cell research. producing new daughter cells. Recently, it has been discovered that stem cells also exist in tissues that were HIERARCHY OF CANCER CELLS conventionally not believed to regenerate, including nerves and skeletal muscles. It can be translated that hu-In 1963, Drs. W. R. Bruce and H. Van der Gaag indicated that only a part of the cells in lymphoma tissue man bodies are composed of multiple stem cell systems like these. In regenerative medicine, taking advantage of can proliferate in vivo (5). Thereby, it has been suspected that a hierarchy also exists for tumor cells. The the potential proliferative capability of stem cells, it has been studied to amplify this capability in vivo and in fact that a very small subset of cells, referred as to cancer stem cells, play a role in the growth and the prolifer-vitro for application in cell therapy. On the other hand, there is a background in which cancer has been focused ation of tumors has been identified not only in hematopoietic malignancies but also in solid organ malignancies, in regenerative medicine, because cancer possesses the same cell hierarchy as is observed in normal tissues. In including brain neoplasms, and breast, prostate, pancreatic, and colon cancers. These cancer stem cells have other words, cancer stem cells have been found to exist. Even if a tumor is cured completely, cancer may recur the unique characteristics of continuing to supply cancer component cells through repeating differentiation and ing reproducibility of cell behaviors. Leukemia was the first cancerous disease for which the existence of a can-self-renewal.
cer stem cell was experimentally proven. In 1997, can-PROPOSING A CANCER STEM CELL THEORY cer stem cells were first identified in human acute myeloid leukemia (AML) by the group of Dick (4). Through The starting point of cancer stem cell theory was when the proliferative capability of various different xenotransplantation in nonobese diabetic severe combined immunodeficiency (NOD/SCID) mice, it was re-cancer cells was verified in vitro and in vivo to discover that only a small subset of cells have marked proliferat-vealed that cells with the ability to induce human AML in NOD/SCID mice exist at a minimal frequency of 0.2-ing abilities (25) . This observation led to the concept that malignant tumors are composed of cancer stem cells 100/10 6 in human AML peripheral mononuclear blood cells and that such cells mainly exist in CD34 + /CD38 − that have active proliferating capabilities and produce daughter cells, differentiated cancer cells with limited fraction. It was in the report of breast cancer by Al-Hajj et al. in 2003 that cancer stem cells were identified in proliferation ability. According to an analysis of the cell surface markers, these cancer stem cells account for less solid cancer (1) . They showed that breast cancer cells in epithelial specific antigen (ESA) + /CD44 + /CD24 −/low have than 1-2% of all cancer cells. According to the conventional concept, cancer cells are heterogeneous, and most characteristics of cancer stem cells. While tumors that are identical to the original breast cancer were formed individual cancer cells proliferate actively and can form new cancers ( Fig. 1A) . Based on the cancer stem cell by implantation of as few as 200 ESA + /CD44 + /CD24 −/ theory, cancer cells are heterogeneous, but only a very low cells into NOD/SCID mice, no tumor formation was observed even when tens of thousands of non-ESA + / small number of cancer stem cells among the cancer cells are capable of proliferating extensively and form-CD44 + /CD24 −/low breast cancer cells were implanted. The results of this experiment, which support such ing new tumors ( Fig. 1B ). Cancer stem cells are similar to normal stem cells in the point that they can produce characteristics as those of cancer stem cells, were reported for solid cancers (10,11,27). Singh et al. stated daughter cells as well as undergo self-renewal.
that a neural stem cell antigen CD133 was expressed in SCIENTIFIC PROOF FOR THE EXISTENCE tumor-derived cancer stem cells in pediatric medul-OF CANCER STEM CELLS loblastoma and astrocytoma (27) . It was also shown that CD133 + cells separated from the aforementioned brain Part of the reason for the difficulty in separating cancer stem cells includes the nature of instability of the tumors, similarly to normal brain stem cells, formed a neurosphere (neural mass) clonally, and proliferated by cell surface status of the cells and complexity in captur- repeating differentiation and self-renewal in vitro. Brain been shown that normal stem cells were transformed to cancer stem cells by dysregulation of a self-renewal pro-tumors were induced by implanting CD133 + cells into NOD/SCID mice; in contrast, no tumors were developed cess, thereby resulting in expansion of tuomrigenic caner cells (2, 15, 32) . after implantation of the cells lacking cell surface expression of CD133 + . Furthermore, the existence of cancer stem cells was consecutively proven for other solid EXISTENCE OF PRECANCEROUS organ cancers such as prostate (23), ovarian (29) , colon STEM CELLS (pCSCs) (21, 26) , and pancreatic cancers (16) . While common It is a fact that most cancers develop from reversible cancer stem cell surface markers, such as CD44 and precancerous pathological conditions such as hyperpla-CD133, are present, there are also cancer stem cells that sia and dysplasia. Cancer stem cells are involved in the have a combination of various cell surface markers formation of these pathological conditions. Recently, (CD34 + /CD38 − for leukemia, ESA + /CD44 + /CD24 −/low for Chen et al. analyzed a dendritic cell-like cell line (DCbreast cancer, CD133 + for brain cancer, CD44 + for proslike clones) isolated from the spleen of mice that had tate cancer, side population cells with Hoechst dye exdeveloped DC-like leukemia, and reported that precanclusion for ovarian cancer, CD133 + for colon cancer, cerous stem cells (pCSCs) were able to differentiate ESA + /CD44 + /CD24 − for pancreatic cancer).
both into benign and malignant forms depending on the environmental cues (7). pCSCs differentiated into vari-ORIGIN OF CANCER STEM CELLS ous normal tissue cells when they are implanted into There are an increasing number of reports that a rare mice with an immune capability; in contrast, formation subgroup of cancer stem cells in cells that compose canof the various types of cancer tissues was induced by cer has high tumorigenicity as well as the functions of implantation of pCSCs into immune-deficient mice. In normal stem cells as described above, but the origin of their reports, the gene expression of c-kit and Sca-1 inthe cancer stem cells is unknown. There is a question as creases in pCSCs, so expression systems of the cells to whether the cancer stem cells are normal stem cells change to the phenotype of CD45 − c-kit − Sca-1 − Lin − → that have changed to malignant or differentiated cells in CD45 − c-kit + Sca-1 − Lin + → CD45 + c-kit + Sca-1 + Lin + to betissue that has dedifferentiated to obtain stem cell charcome cancer stem cells. The proliferating capacity of acteristics. Indeed, cancer stem cells have characteristics pCSCs was controlled by piwil2, which is a testes-specific that are common to normal stem cells, such as a selfexpressed gene that is located on an autosomal chromorenewal capability, the ability to produce differentiated some of PIWI/AGO family in mice. daughter cells, long-lived, resistance to DNA-damaging drugs, and the ability to survive anchorage indepen-MOLECULAR BIOLOGICAL SIGNIFICANCE dently. Therefore, considering these characteristics, re-OF THE CANCER STEM CELL THEORY searchers can easily infer that cancer stem cells are derived from normal stem cells, and that normal stem cells
The cancer stem cell theory is important in creating cancer-harboring animal models and understanding the attain malignant characteristics by gradually accumulating genetic alteration. However, in comparison to ma-interrelationship between interstitium and epithelial cells as well as the mechanism of metastasis. There has been ture cells in tissue, stem cells have a longer life span, so both the accumulation and frequency of the mutation of a considerable amount of progress in creating mouse models of cancer, but very few models can fully repro-genes thereby increases extremely higher. The first step by which a normal stem cell mutates into a cancer stem duce human cancer. Many transgenic mice are designed to express oncogenes in differentiated cells. However, if cell is that the self-renewal process of a stem cell becomes irregular. Pathways of Hedgehog, Notch, Bmi-1, the first step of carcinogenesis is the mutation of genes that are not present in differentiated cells but do exist in Wnt, and PTEN have been reported to involve in stem cell self-renewal. On the other hand, normal stem cells stem cells or stem cell-derived undifferentiated progenitor cells, it cannot be mimicked in a cancer model when have not been identified in many tissues in which the aforementioned tumors develop; thus, it is difficult to oncogenes are transduced into differentiated cells. When oncogenes such as c-Met and c-Myc are transduced into reveal mutations of the genes in which pathways are associated with conversion of normal stem cells into can-the differentiated cells using mouse breast cancer-inducing viruses, breast cancer does not develop, but breast cer stem cells. A recent study has found that Hedgehog pathway in basal cell cancer of the skin is dysregulated cancer can be developed by transduction of these genes in the stem cells (31) . Similarly, a lung cancer model of at an early stage (30) , as is Notch pathway in T-cell acute leukemia, uterine cervix cancer, and breast cancer mice can be created by transducing oncogenes into lung normal stem cells (14) . (19) . In blood malignancies and breast cancer, it has 22 KOBAYASHI ET AL.
CLINICAL SIGNIFICANCE OF THE CANCER
apoptosis and had lower immunogenicity (8). Matsui et al. have reported that myeloma stem cells were more STEM CELL THEORY resistant to chemotherapy and proteasome inhibitors that The cancer stem cell theory leads to a risk assessment were normally used in the clinical settings (17) . It has for cancer and prevention of cancer development. If canalso shown that the percentage of CD133 + cancer stem cer stem cells originate from normal stem cells and uncells in gliomas increases with radiation therapy and that differentiated cells closer to stem cells, then the risk of the cells became more resistance to radiation (3). This cancer thus shows a direct association with the number is because cancer stem cells have a stronger ability to of stem cells that have become problematic. Thereafter, repair DNA damage than do cancer cells. To effectively the pathway that affects the number of stem cells is aslead to a cure for cancer, it is necessary to develop a sociated with the risk of cancer. It is known that the method that targets cancer stem cells. Considering the content of P-16 protein, which acts to limit the number fact that normal stem cells and cancer stem cells have of stem cells, is reduced during the early development similar characteristics and functional aspects, a question of breast cancer (12). It is believed that this causes an arises as to whether only the cancer stem cells can be increase in the number of stem cells and leads to carcitargeted for cure without damaging normal stem cells. nogenesis. This is similarly seen when colon cancer de-Treatments that damage normal stem cells cannot be revelops due to an abnormal Wnt pathway. Conversely, garded as a safe method of treating cancer stem cells. reduction in the number of stem cell leads to a reduced Two recent reports have suggested the feasibility of serisk of cancer. Tamoxifen is used to prevent primary lective treatment of cancer stem cells. breast cancer because of such mechanism of decreasing One report focused on the manipulation of a tumor stem cell number. In addition, the concept of inducing suppressor gene PTEN. When PTEN was conditionally stems cell to differentiated cells and reducing the numdeleted from mature hematopoietic stem cells, the leukeber of stem cells also leads to a reduced risk of cancer mia cancer stem cell population was amplified, but noras well as the development of cancer treatment. There mal hematopoietic stem cells disappeared. By adminishas been a recent report indicating that BMPs are suctering rapamycin (acting to eliminate the effects of cessfully used to differentiate CD133 + cells, which are PTEN deletion) to a leukemia model of mice, the develcancer stem cells of malignant brain tumors, resulting in opment of cancer stem cells was inhibited without damelimination of tumorigenic capacity of CD133 + cells aging normal hematopoietic stem cells (32). In another (24). If a substance specific to cancer stem cells can be report, a cancer stem cell surface marker CD44 was tardiscovered, cancer will be able to be detected at the eargeted by using a monoclonal antibody, and leukemia lier stage than it would be by using conventional tumor stem cells were eradicated in AML-bearing mice (13). markers that are expressed in differentiated cancer cells.
DETECTION OF CANCER STEM CELL TREATMENT STRATEGY BASED MARKERS AND THEIR APPLICATION ON THE CANCER STEM CELL THEORY TO CANCER THERAPY Most conventional cancer treatments have been established based on an assay of what percentage of whole
The group of DeMaria has reported that a subgroup of human colon cancer cells with a CD133 marker has cancer cells can be killed. The sensitivity to cancer stem cells that account for a very small part of cancer compo-carcinogenic abilities in immune-deficient mice, and these carcinogenic cells are cancer stem cells (26). The nent cells may not be measured accurately with such a method. In addition, considering the previous reports report also indicated that, as those cancer cells differentiate in cultures, CD133 + cells lose the ability to form indicating that cancer stem cells are resistant to standard anticancer drugs, the use of such drugs simply reduces tumors in immune-deficient mice. A CD133 + cell needs to remain undifferentiated in order to maintain its own the overall number of tumor cells, which cannot be regarded as an effective anticancer drug in a true sense. carcinogenic ability. By performing genetic analysis and sequencing analysis with undifferentiated CD133 + cells Many standard anticancer drugs can diminish cancerous tissues once, but cancer often recurs. It can be interpre-that had carcinogenic ability as well as CD133 + cells that had lost carcinogenicity in cultures, these cancer stem ted as evidence that cancer stem cells survive and proliferate again to produce daughter cancer cells, so cancer cells were able to be used as an antibody source for dendritic cells that can be used in developing new diag-tissue is newly formed (Fig. 2) . In fact, it has been shown that CD34 + CD38 − leukemia precursor cells were nostic markers for cancer stem cells as well as for vaccines against cancer. By developing compounds for significantly less sensitive to anticancer drugs such as daunorubicin and cyyaarabine than other leukemia cells treatment that specifically targets kinase, which is involved in the proliferation and survival of cancer stem (8). Moreover, the cells were resistant to Fas-induced Treatment strategy for cancer based on cancer stem cell theory. With conventional therapy with standard anticancer drugs, the amount of cancer tissues can be reduced once, but cancer often recurs. It could be explained by the view that cancer stem cells (CSC) exist and are thus able to form new tumors. Therefore, it is necessary to consider a cancer treatment strategy that selectively targets cancer stem cells. cells, it is highly favorable that targeted therapy that is ing the nature (stemness) of cancer stem cells? If the molecular basis thereof can be clarified, it can lead to a capable of killing only cancer stem cells can be developed in the future. In developing such specific cancer significant breakthrough in cancer therapy. If it is necessary for a daughter cell that has been derived from a therapies, protection of personal information associated with patients should be at first an essential issue to be cancer stem cell to enter the niche in order to become independent and grow into a fully grown cancer stem considered. Under the system to protect such information, it is important to develop a cancer stem cell bank cell, the development of a new cancer stem cell could be inhibited by destroying the niche in such a cancer that can strictly control the maintenance of both scientific and clinical data regarding anonymous patients.
tissue. Research on cancer stem cells has just started, but it will be important in the future to reveal how a NICHES IN CANCER STEM CELLS niche is shaped on the molecular level, or if it is a physical space that has a shape, as well as whether it is some-The existence of adult stem cells has been found in thing functional, what determines the nature and ability some tissues and organs, but these stem cells remain of a cancer stem cell to a daughter cancer cell entering undifferentiated without undergoing division, so the therein, and what supports that niche. number of the stem cells is extremely small. It is also Revealing the role of the niche in normal stem cells unknown where the cells exactly exist. Adult stem cells may play a critical role in clarifying the interaction beremain undifferentiated without undergoing division, but tween the interstitium and epithelium, which occurs in division and differentiation begin after they are actithe tumor formation process as well as the mechanism of vated. Assuming that this particular location is a niche, metastasis. For example, CXCR4-which is a cytokine wherein the nature of a stem cell can be maintained receptor that is expressed in normal hematopoietic stem while remaining undifferentiated, it is supposed that cells-is expressed in many types of cancer, including once the stem cell leaves that environment, it will follow breast cancer and prostate cancer, and it is known that an irreversible course from division and proliferation to CXCR4 is involved in neoangiogenesis and tumor differentiation (18, 20) . It can be translated that stem growth through the stimulation of SDF-1 by fibroblast cells hide in a niche and wait to receive signals for acticells (22). This mechanism is closely associated with the vation to begin division, proliferation, and differentiametastasis of breast and prostate cancer (9,28). Moretion. Does such a niche also exist in cancer tissue? If over, it has also been reported that endothelial cells are the niche exists, how does it contribute toward maintain-
